Corona Remedies Ltd share price logo

Corona Remedies Share Price

NSE: CORONA

BSE: 544644

Small Cap

Healthcare Sector

₹1474.60

-27.20

(-1.81%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Corona Remedies Stock Performance

as on February 4, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,461.00
    ₹1,505.00
    downward going graph

    0.92%

    Downside

    2.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,336.60
    ₹1,541.00
    downward going graph

    9.36%

    Downside

    4.50%

    Upside

    downward going graph

Corona Remedies share price movements today

Previous Close
₹1,501.80
Open
₹1,490.00
Volume
14.48K
Upper Circuit
₹1,802.10
Lower Circuit
₹1,201.50
Day's Low - High
₹1,461.00 - ₹1,505.00
52 Week Low - High
₹1,336.60 - ₹1,541.00

Corona Remedies Historical Returns

1 Month Return
+ 2.37 %
3 Month Return
+ 4.41 %
1 Year Return
+ 4.41 %
3 Year Return
+ 4.41 %
5 Year Return
+ 4.41 %

Corona Remedies Fundamentals

as on February 4, 2026 at 4:01 pm IST

Market Cap

₹9,185.02 Cr

Return on Equity (ROE)

27.45

PE Ratio (TTM)

53.62

Return on capital employed (ROCE)

29.78

Industry PE ratio

39.87

Beta (LTM)

0.98

P/B Ratio

0

Dividend Yield

0

PEG Ratio

6.14

Quarterly Earnings Growth YOY

-8.19

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Corona Remedies Stock Valuation

as on February 4, 2026 at 4:01 pm IST

Corona Remedies in the last 5 years

  • Overview

  • Trends

Lowest (47.11x)

December 24, 2025

Industry (39.87x)

February 3, 2026

Today (53.62x)

February 3, 2026

Highest (53.77x)

January 19, 2026

LowHigh

Today’s Price to Earnings Ratio: 53.62x

Corona Remedies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corona Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Corona Remedies Ltd image
Corona Remedies Ltd
BUY9,185.020.88%0.591491,196
Gennex Laboratories Ltd image
Gennex Laboratories Ltd
NA298.8329.6%0.5818137
Shilpa Medicare Ltd image
Shilpa Medicare Ltd
BUY5,866.487.14%0.60781,286
Sat Kartar Shopping Ltd image
Sat Kartar Shopping Ltd
NA232.24-1.74%0.009162
ANG Lifesciences India Ltd image
ANG Lifesciences India Ltd
NA31.72-4.32%0.78-1392
See all

Analyst Recommendation on Corona Remedies Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Corona Remedies. Average target price of ₹1685

Source: S&P Global Market Intelligence

Corona Remedies Share Price Target

Get share price movements and forecasts by analysts on Corona Remedies.

What analysts predicted

12.2%UPSIDE

Target Price

₹1685

Current Price

₹1474.6

Analyzed by

1 Analysts

High

₹1685

Target

₹1685.00

Low

₹1685

Corona Remedies target price ₹1685, a slight upside of 12.2% compared to current price of ₹1474.6. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Corona Remedies Stock’s Investor Sentiment and Interest

Search interest for Corona Remedies Ltd Stock has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-83% versus previous 30 day period

Corona Remedies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
291.17
313.87
297.69
293.69
346.54
361.13
342.42
Other Income
1.29
2.46
0.94
1.63
2.02
2.44
2.26
Total Income
292.46
316.33
298.63
295.32
348.56
363.57
344.68
Expenses
241.65
247.06
228.27
239.47
276.96
282.66
278.36
Operating Profit
49.52
66.81
69.42
54.22
69.58
78.47
64.06
Operating Profit Margin %
17.01%
21.29%
23.32%
18.46%
20.08%
21.73%
18.71%
Profit Before Interest, Tax and Depreciation
50.81
69.27
70.36
55.85
71.6
80.91
66.32
Interest
3.15
2.87
2.39
2.2
1.99
1.93
1.66
Depreciation
8.38
9.05
9.69
10.04
8.92
9.2
9.45
Profit Before Tax
39.28
57.35
58.28
43.61
60.69
69.78
55.21
Tax Paid
9.33
14.38
13.33
12.06
14.49
17.46
13.94
Profit After Tax
29.95
42.97
44.95
31.55
46.2
52.32
41.27
Total Net profit including share of profit / Loss from associate company
29.95
42.97
44.95
31.55
46.2
52.32
41.27
EPS
4.9
7.03
7.35
5.16
7.55
8.55
6.75
Actual EPS
4.9
7.03
7.35
5.16
7.55
8.55
6.75
Adjusted EPS
4.9
7.03
7.35
5.16
7.55
8.55
6.75
Diluted EPS
-
7.03
7.35
-
7.55
8.55
6.75

Corona Remedies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Sales
884.05
1,014.47
1,196.42
Other Income
7.28
6.46
6.31
Total Income
891.33
1,020.94
1,202.73
Expenses
756.07
859.74
956.44
Operating Profit
127.98
154.73
239.98
Operating Profit Margin %
14.48%
15.25%
20.06%
Profit Before Interest, Tax and Depreciation
135.26
161.2
246.29
Interest
4.27
14.44
10.6
Depreciation
20.1
28.28
37.16
Profit Before Tax
110.89
118.48
198.53
Tax Paid
25.96
27.98
49.1
Profit After Tax
84.93
90.5
149.43
Total Net profit including share of profit / Loss from associate company
84.93
90.5
149.43
EPS
14.57
14.8
24.43
Actual EPS
14.57
14.8
24.43
Adjusted EPS
14.57
14.8
24.43
Diluted EPS
14.57
14.8
24.43

Corona Remedies Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
102.7
156.76
190.5
Cash Flow from Investing Activities
-50.28
-266.64
-83.84
Cash Flow from Financing Activities
-44.75
98.54
-106.59
Net Cash Flow
7.67
-11.34
0.07

Corona Remedies Stock Shareholding Pattern

Numbers in percentages

Apr 2025
Dec 2025
Promoters
72.5%
69%
DII
0%
6.76%
FII
0%
1.84%
Public
0%
22.4%
Total Outstanding Shares
6,11,60,088
6,11,60,088
Total Shareholders
9
31,035

Mutual Funds that own Corona Remedies Stock

Check out the Mutual Funds with significant holdings in Corona Remedies.

Corona Remedies Corporate Actions

View detailed summary of the earnings and dividend history of Corona Remedies.

  • Corona Remedies Ltd Earnings Results

    Corona Remedies Ltd’s net profit fell -8.19% since last year same period to ₹41.27Cr in the Q3 2025-2026. On a quarterly growth basis, Corona Remedies Ltd has generated -21.12% fall in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Corona Remedies Stock

Check stock indices that include Corona Remedies.

BSE IPO

₹15,177.82

0.41 (▲62.13%)

Insights on Corona Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 1.84% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CORONA stock has moved up by 5.9%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 0.00% to 22.40% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.00% to 6.38% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.50% to 69.00% in Dec 2025 quarter

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited a private limited company dated August 27 2004 issued by the Assistant Registrar of Companies Gujarat at Dadra and Nagar Haveli. Thereafter Company converted into a public limited and Company name has changed to CORONA Remedies Limited. A fresh certificate of incorporation is issued by the Registrar of Companies Central Processing Centre Manesar Haryana on December 16 2024.The manufacturing facilities of the Company are located at Solan Himachal Pradesh and at Bhayla Ahmedabad Gujarat. The Company is engaged in manufacturing trading and marketing of Pharmaceutical products in womens healthcare cardiodiabeto pain management urology and other therapeutic areas. In 2004 Company launched the first division and later named it as Pioneer division in year 2010 launched Xemx multispeciality division in 2005. The production of first manufacturing plant was commissioned at Solan Himachal Pradesh in 2007. The Company launched Gynaecology division in 2008 further launched Cardioloy division in 2013 launched Cardiovascular disease CVD and Solis division in 2016. Later the production at Ahmedabad Plant commissioned in Gujarat in 2021. Radiance and Solaris Divisions launched in 2022 followed by Urology division in 2023. Company is planning an IPO by raising funds of Rs 800 Cr equity shares of Rs 10 each through offer for sale..

Revenue: ₹342.42Cr as on December 2025 (Q3 FY26)
Net Profit: ₹41.27Cr as on December 2025 (Q3 FY26)
Listing date: 15 Dec, 2025
OrganisationCorona Remedies Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Corona Remedies share price today?

Corona Remedies share price today stands at ₹1474.6 as on at the close of the market. Corona Remedies share today touched a day high of ₹1505 and a low of ₹1461.

What is the 52 week high and 52 week low range for Corona Remedies share?

Corona Remedies touched a 52 week high of ₹1541 and a 52 week low of ₹1336.6. Corona Remedies share price today i.e. is closed at ₹1474.6, which is -4.31% down from its 52 week high and 10.32% up from its 52 week low.

What is Corona Remedies's market capitalisation today?

Corona Remedies market capitalisation is ₹9,185.02 Cr as on .

How to buy Corona Remedies shares?

To buy Corona Remedies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for CORONA or Corona Remedies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Corona Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Corona Remedies trading volume today?

Corona Remedies trading volume is 14.48K as on . This means that 14.48K shares of Corona Remedies were bought and sold on the stock market during today's trading session.